Hong Kong OTC Clearing Rules: Standard Calculation Periods From 2027

On 29 January 2026 the Hong Kong Monetary Authority (HKMA) and the Securities and Futures Commission (SFC) issued a joint consultation on a small but consequential part of the Hong Kong OTC clearing rules: the calculation periods that decide when a firm is caught by the mandatory clearing obligation. The regulators proposed to stop adding calculation periods to the Clearing Rules in dated batches and instead fix them by a standing formula, with effect from 1 March 2027. The comment window closed on 27 February 2026, and on 5 June 2026 the two authorities published conclusions confirming broad market support and their intention to proceed.

The headline for anyone who runs the clearing-threshold test is that almost nothing about the test itself moves. The clearing threshold stays at USD 20 billion. Each calculation period stays three months long, two per calendar year. The seven-month lead time before a new clearing obligation bites, the point the Rules call the Prescribed Day, stays where it is. What changes is the mechanism for generating future periods, and therefore how far ahead a prescribed person can read its own compliance calendar without waiting for the next legislative amendment.

The regulators state that the formulaic approach does not engender operational changes relating to compliance with the Clearing Rules. Firms should nevertheless assess whether internal calendars, rule inventories, threshold controls and legislative-status monitoring require updates; the extent of any systems work is firm-specific.

Related reading: our EMIR reporting guide

The dates that matter before and after the switch

Because the whole point of the change is calendar certainty, start with the calendar. The following dates are drawn from the January 2026 consultation paper, its draft Schedule 2, and the June 2026 conclusions.

  • 29 January 2026: HKMA and SFC issue the joint consultation on standard calculation periods.
  • 27 February 2026: deadline for written comments to the HKMA or the SFC.
  • 5 June 2026: the regulators publish consultation conclusions, reporting broad support and confirming they will proceed.
  • Fourth quarter of 2026: the latest official target, stated in the June 2026 Legislative Council Panel paper, for tabling the proposed amendments for negative vetting.
  • 1 September 2026 to 30 November 2026: the last calculation period explicitly listed in the current Schedule 2, with a Prescribed Day of 1 July 2027.
  • 1 March 2027: proposed commencement of the amended Rules and the first calculation period generated by the new formula.
  • 1 March to 31 May 2027: first formula-driven calculation period, with a Prescribed Day of 1 January 2028.
  • 1 September to 30 November 2027: second formula-driven calculation period, with a Prescribed Day of 1 July 2028.

There is no gap in the sequence. The spring and autumn 2026 periods already sit in Schedule 2 as dated rows, and the proposed formula begins with the Calculation Period starting on 1 March 2027.

What the Hong Kong OTC clearing rules change actually does

Since mandatory clearing began in Hong Kong, each calculation period has been written into Schedule 2 to the Clearing Rules as a dated row: a start date, an end date, the USD 20 billion clearing threshold, and a Prescribed Day. When the list ran low, the regulators consulted and added more rows. That is how sixteen additional periods were added after the 2018 and 2021 consultations, extending the schedule to a final listed period ending on 30 November 2026.

The 2026 proposal replaces the dated rows for 2027 onward with two standing entries, converting the schedule from a table of dates into a repeating rule. In the draft Schedule 2, the new items read, in effect, that from 1 March 2027 onward the periods 1 March to 31 May and 1 September to 30 November in each year are calculation periods, each carrying the USD 20 billion clearing threshold and a Prescribed Day in the following year. The schedule stops being a list that expires and becomes a formula that regenerates.

It is worth being precise about scope. The amendment creates no new clearing obligation, expands no product coverage, and leaves the threshold at USD 20 billion. Only the source of the dates moves, from dated Schedule 2 rows to a standing rule, and the obligation, threshold, and instrument scope all remain exactly as they were.

How a calculation period decides the clearing obligation

The calculation period only matters because of what hangs off it. Under rule 6 of the Clearing Rules, the mandatory clearing obligation for a prescribed person arises when its applicable average (local) total position in relevant OTC derivative transactions, measured over a calculation period, reaches the clearing threshold for that period. That threshold is currently USD 20 billion. The position figure is a defined average calculated under the Rules, and the precise method sits in the Rules and in the SFC’s published Frequently Asked Questions on the implementation and operation of the mandatory clearing regime.

Two features of the timing warrant precision. First, a calculation period is a measurement window; reaching the threshold inside it triggers no immediate clearing obligation. Second, the obligation attaches from the Prescribed Day, which the Rules set seven months after the end of the relevant calculation period. That gap is deliberate: it gives a dealer that crosses the threshold for the first time to put clearing arrangements in place before it has to clear. Under the proposed formula, if the applicable position for the 1 March to 31 May 2027 Calculation Period equals or exceeds the clearing threshold, the corresponding Prescribed Day would be 1 January 2028; if it equals or exceeds the threshold for the 1 September to 30 November 2027 period, the corresponding Prescribed Day would be 1 July 2028.

The exit test is separate from the Calculation Period test. Under rule 6(3), a person may give an exit notice only after its applicable gross position at each month-end has remained below the US$14 billion exit threshold for 12 consecutive months and the other notice conditions have been met. The person remains treated as having reached the clearing threshold until it gives the exit notice.

Who counts as a prescribed person

The obligation runs to prescribed persons, and the term is narrower than derivatives market participant. Under the Clearing Rules a prescribed person is an authorized institution or an approved money broker under the Banking Ordinance, or a licensed corporation under the Securities and Futures Ordinance. A bank supervised by the HKMA and a Hong Kong licensed corporation can both be prescribed persons; a corporate end user hedging its own book generally is not. If your entity does not fall into one of those categories, the calculation-period machinery does not reach it directly, though your prescribed-person counterparties will still be running the test on their side.

Scope has two separate dimensions. For the clearing-threshold calculation, a local authorized financial institution, approved money broker or licensed corporation uses its average total position. A non-local institution in those categories uses its average local total position, which takes account only of positions booked in its Hong Kong branch. The calculation is performed on a gross-notional basis and generally includes all outstanding OTC derivative transactions, including transactions exempt from clearing or outside the current clearing-product scope, except deliverable foreign-exchange forwards and deliverable foreign-exchange swaps. Intra-company transactions between two trading desks, or between branches or offices of the same entity, need not be included. Product and counterparty status determine whether a future transaction must be cleared after the relevant Prescribed Day: it must be a specified OTC derivative transaction, and the counterparty must either be an authorized institution, approved money broker or licensed corporation that is also required to clear that transaction, or a designated financial services provider. The financial-services-provider list is reviewed annually.

Why the regulators moved from a list to a formula

The consultation paper gives a candid rationale, and it is mostly about operational drag. Re-legislating the schedule every few years to add periods is administratively heavy for a change that has become entirely predictable. The regulators observed that two three-month periods a year has worked, that the seven-month Prescribed Day has given first-time dealers enough runway, and that the USD 20 billion threshold has stayed appropriate. Over the life of the regime the number of prescribed persons that have reached the clearing threshold has risen from 17 to 27 between 2017 and 2025, which the authorities read as evidence the framework is calibrated about right.

Consistent six-month intervals between period start dates catch new dealers and expanding books on a regular cadence and blunt any incentive to shrink a position inside a single window to duck the threshold. Locking the periods to a formula preserves that anti-timing design while removing the need to keep passing amendments. The switch formalises a pattern the regulators have applied consistently twice before, locking in what has worked without touching the three design levers: period length, frequency, or threshold.

What does not change for clearing and reporting teams

For an operations or regulatory-reporting function, the honest answer is that the day-to-day does not move. You still measure the applicable average position over each three-month period, still test it against USD 20 billion, still watch the Prescribed Day if you cross, and still work from the SFC’s mandatory clearing FAQ for the calculation detail. The regulators themselves note the formulaic approach does not create operational changes for compliance with the Rules.

The risk is a comforting misread: a standing formula fixes the calendar without calculating the position or identifying when the threshold is crossed. The obligation to measure the average position each period, test it against USD 20 billion, and stand ready by the Prescribed Day remains squarely with the prescribed person. The proposal increases forward calendar certainty, allowing firms to schedule the two annual threshold calculations and related readiness checks in advance.

If the amendment is enacted and comes into force as proposed, teams may replace reminders for periodic Schedule 2 extensions with controls covering the standing 1 March to 31 May and 1 September to 30 November windows. Until then, firms should retain legislative-status monitoring and continue to apply the current Schedule 2.

How Hong Kong’s threshold test compares with EMIR

Practitioners who also run EU books should keep the regimes separate. Under EMIR Article 4a as replaced by Regulation (EU) 2024/2987, a financial counterparty may calculate every 12 months both its uncleared positions and its aggregate month-end average positions in cleared and uncleared OTC derivatives for the previous 12 months. If it does not calculate either relevant measure, or the result exceeds the applicable threshold, it must notify ESMA and its competent authority, establish clearing arrangements within four months and become subject to the clearing obligation for all OTC derivative contracts pertaining to a class subject to that obligation that are entered into or novated more than four months after notification. Hong Kong instead uses two scheduled three-month Calculation Periods, a US$20 billion threshold and a Prescribed Day seven months after each period ends.

The exit mechanics also differ. Under current EMIR Article 4a(2), a financial counterparty remains subject until it demonstrates to its competent authority that its aggregate positions or uncleared positions do not exceed the applicable clearing thresholds. Hong Kong instead uses a separate exit test: the applicable gross position must remain below US$14 billion at every month-end for 12 consecutive months, followed by an exit notice. If you want the EU comparators in detail, our note on the EMIR 3 clearing thresholds and active account requirement sets out how the European numbers and the active account overlay work, and the active account reporting templates show the reporting layer that Hong Kong does not mirror. Neither EU instrument governs the Hong Kong obligation; they illustrate how a comparable regime handles the same design questions.

What to confirm before 1 March 2027

The regulators do not expect the formulaic approach itself to create operational changes, but firms should complete proportionate implementation checks. Confirm whether the entity is an authorized institution, approved money broker or licensed corporation. Prepare calendar controls for the proposed standing periods, while continuing to monitor and apply the current Schedule 2 until the amendment takes effect. Verify the position-aggregation methodology against the governing Clearing Rules and use the joint HKMA/SFC FAQ as official explanatory guidance.

Then watch the legislative step. The proposed amendment will be made as subsidiary legislation subject to negative vetting in the Legislative Council. The latest official timetable, in the June 2026 Legislative Council Panel paper, is to table the amendments in the fourth quarter of 2026, with implementation proposed for 1 March 2027. Until the legislative process is complete, that commencement date is not enacted and should be treated as expected rather than confirmed.

Frequently Asked Questions

Does the USD 20 billion clearing threshold change under the 2026 proposal?

No. The draft Schedule 2 keeps the clearing threshold at USD 20 billion for both the existing dated periods and the new formula-driven periods from 1 March 2027. The proposal changes how future calculation periods are generated; it leaves the threshold, the period length, and the Prescribed Day timing all unchanged.

If we cross the threshold in the first formula period, when must we clear?

If the applicable position for the 1 March to 31 May 2027 Calculation Period equals or exceeds the clearing threshold, the corresponding Prescribed Day would be 1 January 2028. If it equals or exceeds the threshold for the 1 September to 30 November 2027 period, the corresponding Prescribed Day would be 1 July 2028. Subject to the other conditions in the Clearing Rules, mandatory clearing applies to specified OTC derivative transactions entered into on or after that Prescribed Day; it does not arise on an intra-period ‘crossing’ date.

Does the formula remove our obligation to monitor Schedule 2?

If enacted as proposed, the amendment would remove the need to wait for further dated rows to be added to Schedule 2. It would not remove the underlying obligation to perform the Calculation Period test and prepare for the relevant Prescribed Day. Until the amendment takes effect, firms should continue to monitor the legislative process and apply the current Schedule 2.

We only face corporate clients, not banks or licensed corporations. Are we caught?

The threshold calculation is not limited to trades with banks, licensed corporations or financial services providers. A local authorized financial institution, approved money broker or licensed corporation uses its average total position, while a non-local institution in those categories uses its average local total position booked in its Hong Kong branch. The calculation is performed on a gross-notional basis and generally includes all outstanding OTC derivative transactions, except deliverable foreign-exchange forwards and deliverable foreign-exchange swaps; intra-company transactions between two trading desks, or between branches or offices of the same entity, need not be included. Separately, a future transaction is subject to mandatory clearing only if it is a specified OTC derivative transaction and the counterparty is either an authorized financial institution, approved money broker or licensed corporation that is also required to clear the transaction, or a designated financial services provider.

What actually gets cleared under the Hong Kong regime?

Mandatory clearing took effect on 1 September 2016 for specified standardised interest rate swaps among major dealers where the conditions in the Clearing Rules are met. The precise product and currency scope is set out in the Clearing Rules and the SFC’s mandatory clearing FAQ, which is the source to check before treating any given swap as in or out of scope.

Is the 1 March 2027 date confirmed?

As of the June 2026 conclusions, the regulators have confirmed that they will proceed and have proposed commencement on 1 March 2027, but the amending Rules remain subsidiary legislation subject to negative vetting in the Legislative Council. Calendar 1 March 2027 as the expected commencement date and confirm it against the final amending Rules and their commencement provision once the legislative process is complete.

Does any of this affect mandatory reporting rather than clearing?

The 2026 consultation does not amend Hong Kong’s separate mandatory reporting regime. It also does not change the substantive record-keeping duty in the Clearing Rules. However, records under rule 14 must be sufficient to demonstrate whether rule 6(1) applied, so clearing-related record-keeping controls should reflect the new Schedule 2 Calculation Periods and Prescribed Days if the amendment is enacted.

Key Takeaways

  • HKMA and SFC intend to amend Schedule 2 so that, from 1 March 2027, 1 March to 31 May and 1 September to 30 November in each year would become standing Calculation Periods. The amendment remains subject to completion of the legislative process and negative vetting.
  • The clearing threshold stays at USD 20 billion, each period stays three months, and the Prescribed Day stays seven months after each period ends. The mechanism for generating periods changes; the obligation, threshold and period structure do not.
  • If the applicable position equals or exceeds the threshold for the proposed 1 March to 31 May 2027 Calculation Period, the corresponding Prescribed Day would be 1 January 2028; for the proposed 1 September to 30 November 2027 period, it would be 1 July 2028.
  • Prescribed persons are authorized institutions and approved money brokers under the Banking Ordinance and licensed corporations under the Securities and Futures Ordinance. Corporate end users are generally outside the test.
  • After the relevant Prescribed Day, mandatory clearing applies only to specified OTC derivative transactions where the counterparty is either an authorized institution, approved money broker or licensed corporation that is also required to clear the transaction, or an SFC-designated financial services provider. This transaction-level test is separate from the broader threshold calculation.
  • The comment period closed on 27 February 2026 and conclusions were published on 5 June 2026; commencement on 1 March 2027 remains subject to negative vetting in the Legislative Council.
  • Action before the switch: confirm entity classification, prepare calendar controls for the proposed standing periods, and verify the position calculation against the governing Clearing Rules, using the joint HKMA/SFC FAQ as explanatory guidance.

Sources and References

  • HKMA press release, HKMA and SFC jointly consult on standard calculation periods under OTC derivative Clearing Rules, 29 January 2026: hkma.gov.hk
  • HKMA and SFC, Joint consultation paper on proposed amendments to the Clearing Rules for over-the-counter derivative transactions, January 2026 (PDF, including draft Schedule 2): hkma.gov.hk (PDF)
  • HKMA press release, HKMA and SFC conclude joint consultation on amendments to the Clearing Rules for over-the-counter derivative transactions, 5 June 2026: hkma.gov.hk
  • HKMA and SFC, Frequently Asked Questions on the Implementation and Operation of the Mandatory Clearing Regime, October 2025: sfc.hk (PDF)
  • Securities and Futures (OTC Derivative Transactions, Clearing and Record Keeping Obligations and Designation of Central Counterparties) Rules (Cap. 571AN), Hong Kong e-Legislation: elegislation.gov.hk
  • Securities and Futures Ordinance (Cap. 571), Hong Kong e-Legislation, including sections 101N and 101P: elegislation.gov.hk
  • Legislative Council Panel on Financial Affairs, Implementation of Standardised Calculation Periods under the Over-the-counter Derivatives Regulatory Regime in Hong Kong, LC Paper No. CB(1)754/2026(01), June 2026: legco.gov.hk (PDF)
  • Regulation (EU) 2024/2987, Article 1(4), replacing EMIR Article 4a: EUR-Lex
  • ISDA response to the HKMA and SFC consultation on the Clearing Rules, March 2026: isda.org

Before the 1 March 2027 switch

The proposed amendment would standardise the Calculation Period calendar without changing the US$20 billion clearing threshold, three-month period length or seven-month Prescribed Day. Prescribed persons should prepare for the expected 1 March 2027 implementation, verify the position calculation against the governing Clearing Rules and the joint HKMA/SFC FAQ, and confirm the final amending Rules and commencement date after the negative-vetting process.

Disclaimer: The information on RegReportingDesk.com is for educational and informational purposes only. It does not constitute legal, regulatory, tax, or compliance advice. Always consult your compliance officer, legal counsel, or the relevant supervisory authority for guidance specific to your institution.

Similar Posts

  • Gas Derivatives Reporting After the GMTF: EMIR and REMIT for Energy Firms

    Updated July 2026In this guideWhy the GMTF report matters for your reporting stackTwo regimes, two destinations: EMIR and REMITWhere gas derivatives reporting actually starts: EMIR Article 9Energy firms as non-financial counterparties, and the EMIR 3 threshold questionREMIT data collection: what ACER expects, and what it does not coverPosition management controls and position reporting under MiFID…

  • Transaction Reporting Simplification: ESMA’s EUR 1bn Plan

    Updated July 2026In this guideThe EUR 1 billion figure, and what sits behind itKey dates on the transaction reporting simplification trackThe three regimes in scope: EMIR, MiFIR and SFTRWhy duplication costs so much todayThe two-track plan: near-term fixes and a long-term architectureWhat “report once” does not mean for your obligationsThe legislative backdrop already points this…

  • OTC Derivatives Consolidated Tape: ESMA Names the First Provider

    Updated July 2026In this guideWhat ESMA selected, and for how longThe dates that matterWhy this is a MiFIR event while your EMIR reports stay putWho is responsible for the OTC prints that feed the tapeThe reference-data change that reaches your buildWhat the tape raises the stakes onFrequently Asked QuestionsRelated ArticlesKey TakeawaysSources and ReferencesWhat to line…

  • EMIR Initial Margin Reporting – What the New IM Model Authorisation Regime Means for Your Firm

    Updated July 2026In this guideHow Initial Margin Works Under EMIRWhat EMIR 3 Changes for Initial Margin ModelsThe EBA Consultation on IM Model AuthorisationFees for Pro Forma Model ValidationThe Authorisation Process Step by StepWhat Falls Under “Model Changes”The Standardised Schedule AlternativeLuxembourg and the CSSFTimeline and Key DatesWhat Compliance Officers Should Do NowFrequently Asked QuestionsRelated ArticlesKey TakeawaysSources…